Skip to main content

Table 1 Clinical characteristics of patients with sarcoidosis

From: TL1A/DR3 axis involvement in the inflammatory cytokine network during pulmonary sarcoidosis

Patients with active sarcoidosis (n = 29)
 Stage 1 (bilateral hilar lymphadenopathy) 13
 Stage 2 (bilateral hilar lymphadenopathy with pulmonary infiltrates) 11
 Stage 3 (parenchymal infiltrates without hilar adenopathy) 5
 FVC% 103.33 ± 11.60
 FEV1% 101.16 ± 14.76
 DLCO% 79.33 ± 11.13
 TIFF 92.00 ± 12.94
Patients with inactive sarcoidosis (n = 14)
 Stage 1 11
 Stage 2 3
 Stage 3 0
 FVC% 98.20 ± 15.39
 FEV1% 93.10 ± 17.99
 DLCO% 86.77 ± 10.72
 TIFF 80.01 ± 8.99
  1. FVC, Forced vital capacity; FEV1, Forced Expiratory Volume in the first second; DLCO, Diffusing Capacity of the Lung for Carbon Monoxide; TIFF, Tiffeneau index